Degree Name

Nursing Practice, DNP

Publication Date

2020

Upload Date

2024

First Advisor

L. Todd Hamon

Abstract

Total knee arthroplasty (TKA) is the definitive treatment for degenerative joint disease of the knee. Total joint infections, although low, are a complication that can be a massive expenditure on health care systems and patients. Economic costs have the potential of being high for this procedure. It is estimated to treat these TKA infections, primarily methicillin-resistant Staphylococcus aureus (MRSA) to be between $68,000 and $107,000. The purpose of this retrospective study is to determine whether vancomycin has greater cost benefits and efficacy in reducing post-operative infection rate of total knee arthroplasties than does cefazolin.

Creative Commons License

Creative Commons Attribution 4.0 International License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Share

COinS